The recent announcement of former President Biden's prostate cancer diagnosis raises questions about the transparency of his health. Critics argue that his medical team previously obscured his cognitive decline during his presidency, suggesting a lack of trust in current health disclosures. Prostate cancer detection relies on yearly screenings, which Biden's medical care team should employ, raising concerns whether he was adequately screened. As modern treatments improve, there remains a strong argument for routine screening even in older age brackets for better health management.
Prostate cancer does not occur overnight, and proper screening with yearly Prostate Specific Antigen tests and a digital rectal exam should pick it up the vast majority of the time.
There are newer personalized screening approaches emerging, including genetic testing, liquid biopsy, urine-based biomarker tests and the use of artificial intelligence.
Collection
[
|
...
]